Fed. Circ. Rules Apotex's Fosamax Appeal Moot
Apotex said it plans to begin marketing a generic version of Fosamax in next month.
Apotex had appealed an April 2007 ruling by the U.S. District Court for the District of Delaware that allowed Merck to drop a lawsuit accusing Apotex of infringing the patent for Fosamax. Merck sued after...
To view the full article, register now.